We have just released the latest data update to the Open Targets Platform — 22.06.
Key highlights for this release:
We have included five additional studies in our Gene Burden widget, incorporating evidence from several therapeutic areas
The term “medical procedure” now exists in our ontology
Users can now visualise subcellular locations of targets
This release integrates 14,455,104 evidence strings to build 7,247,865 target-disease associations between 23,074 diseases and 61,524 targets from the following 22 public resources:
For the latest release of the UI and the followings, we are using the OT-UI-APPS repository. GitHub - opentargets/ot-ui-apps We are working on enforcing the documentation, but basically, this repo will replace platform-app and genetics-app.
Thank you for the explanation. I didn’t realize the ot-ui-apps repo was already used in production but that certainly explains why there is no release tag in the platform-app repo. I’ll check out the new repo in more detail then.
Hi Helena, some questions on the statistics of 22.06. I saw the annotation of the Drugs came from ChEMBL, including different level clinical precedence.
Is it means 12,854 drugs with 596,593 ( * 596,593 drug evidence from ChEMBL ) evidence all extracted from ChEMBL database?
Do these 12,854 drugs also include compounds haven’t been approved ?
Yes, our drugs and drug evidence is extracted from the ChEMBL database (ChEMBL is the only source of evidence in the data type ‘Drugs’, but we do have additional annotation data e.g. from FAERS.)
The evidence extracted from ChEMBL includes approved drugs and clinical candidates